Company’s 36-month beta value is 1.64.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ANVS is 8.14M, and currently, short sellers hold a 18.48% ratio of that floaft. The average trading volume of ANVS on April 23, 2024 was 244.67K shares.
ANVS) stock’s latest price update
The stock of Annovis Bio Inc (NYSE: ANVS) has increased by 14.21 when compared to last closing price of 10.06.Despite this, the company has seen a gain of 3.61% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-08 that The average of price targets set by Wall Street analysts indicates a potential upside of 218.9% in Annovis Bio (ANVS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ANVS’s Market Performance
Annovis Bio Inc (ANVS) has seen a 3.61% rise in stock performance for the week, with a -2.87% decline in the past month and a -11.14% plunge in the past quarter. The volatility ratio for the week is 12.73%, and the volatility levels for the past 30 days are at 8.87% for ANVS. The simple moving average for the past 20 days is 2.55% for ANVS’s stock, with a 7.37% simple moving average for the past 200 days.
Analysts’ Opinion of ANVS
Many brokerage firms have already submitted their reports for ANVS stocks, with Canaccord Genuity repeating the rating for ANVS by listing it as a “Buy.” The predicted price for ANVS in the upcoming period, according to Canaccord Genuity is $36 based on the research report published on December 29, 2023 of the previous year 2023.
Maxim Group, on the other hand, stated in their research note that they expect to see ANVS reach a price target of $150, previously predicting the price at $45. The rating they have provided for ANVS stocks is “Buy” according to the report published on July 07th, 2021.
ANVS Trading at 11.34% from the 50-Day Moving Average
After a stumble in the market that brought ANVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.91% of loss for the given period.
Volatility was left at 8.87%, however, over the last 30 days, the volatility rate increased by 12.73%, as shares surge +1.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.00% upper at present.
During the last 5 trading sessions, ANVS rose by +3.61%, which changed the moving average for the period of 200-days by -15.45% in comparison to the 20-day moving average, which settled at $11.21. In addition, Annovis Bio Inc saw -38.56% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ANVS
The total capital return value is set at -4.21. Equity return is now at value -546.40, with -243.15 for asset returns.
Currently, EBITDA for the company is -45.04 million with net debt to EBITDA at 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.39.
Conclusion
In a nutshell, Annovis Bio Inc (ANVS) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
